Concentración fecal de la preparación de vancomicina intravenosa posterior a administración oral en un modelo experimental: ensayo preclínico

Concentración fecal de la preparación de vancomicina intravenosa posterior a administración oral en un modelo experimental: ensayo preclínico

Resumen: Introducción: La infección por Clostridioides difficile es la principal causa de diarrea nosocomial. El tratamiento de primera línea es vancomicina oral; sin embargo, esta presentación no está disponible comercialmente en Latinoamérica. Nuestro objetivo fue determinar la concentración feca...

Full description

Bibliographic Details
Main Authors:	J. Ramos-García, F. Robles-Rivera, M. Chávez-Soto, M. Valdés, F. Calzada, N. Ortiz-Olvera
Format:	Article
Language:	Spanish
Published:	Elsevier 2023-04-01
Series:	Revista de Gastroenterología de México
Subjects:	Clostridioides difficile Fecal concentration Minimum bactericidal concentration Preclinical assay Vancomycin
Online Access:	http://www.sciencedirect.com/science/article/pii/S0375090621001245

Similar Items

Concentración fecal de la preparación de vancomicina intravenosa posterior a administración oral: datos preclínicos que sustentan necesidades clínicas no satisfechas
by: Juan Asbun-Bojalil
Published: (2023-04-01)

Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study
by: Marcos Hernando-Gozalo, et al.
Published: (2024-05-01)

<i>Clostridioides difficile</i> infection in hospital and community settings: summary document of a multidisciplinary group
by: Anna Danise, et al.
Published: (2024-02-01)

The Clinical Efficacy, Safety, and Tolerability of Vancomycin for the Treatment of Recurrent Clostridioides difficile Infection – A Systematic Review
by: Knudsen MJS, et al.
Published: (2023-03-01)

Antimicrobial Resistance of Clostridioides difficile in Children from a Tertiary Pediatric Hospital in Shanghai, China
by: Li X, et al.
Published: (2024-01-01)

Efficacy of prolonged tapered and pulsed vancomycin regimen on recurrent Clostridioides difficile infection in the Japanese setting: a case control study
by: Takumi Umemura, et al.
Published: (2019-08-01)

<i>Clostridioides difficile</i> – a new name, the old problems with diagnosis and treatment
by: Sergey M. Zakharenko
Published: (2023-01-01)

Activity of omadacycline in vitro against Clostridioides difficile and preliminary efficacy assessment in a hamster model of C. difficile-associated diarrhoea
by: Raina Gay Leahy, et al.
Published: (2022-09-01)

The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
by: Ronald G. Hall, et al.
Published: (2022-02-01)

Auranofin and Baicalin Inhibit Clostridioides difficile Growth and Sporulation: An In vitro Study
by: Lamiaa A. Madkour
Published: (2022-09-01)

Encapsulation protocol for fecal microbiota transplantation
by: Dávid Sipos, et al.
Published: (2024-06-01)

Fecal concentration of intravenous vancomycin preparation after oral administration in an experimental model: preclinical assay
by: J. Ramos-García, et al.
Published: (2023-04-01)

Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model
by: Jingpeng Yang, et al.
Published: (2022-04-01)

ANTIDEPRESSANT MEDICATIONS ARE ASSOCIATED WITH INCREASED RISK OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES DIFFICILE INFECTION: A POPULATION-BASED STUDY
by: Antoine BOUSTANY, et al.
Published: (2023-09-01)

Outbreak of Clostridioides difficile infection in Silesian district hospital
by: Klaudia T. Szarek, et al.
Published: (2023-06-01)

Review of the Impact of Biofilm Formation on Recurrent <i>Clostridioides difficile</i> Infection
by: Daira Rubio-Mendoza, et al.
Published: (2023-10-01)

The Effect of Subinhibitory Concentration of Metronidazole on the Growth and Biofilm Formation on Toxigenic <i>Clostridioides difficile</i> Strains Belonging to Different Ribotypes
by: Dorota Wultańska, et al.
Published: (2023-10-01)

Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
by: Hyuk Yoon, et al.
Published: (2021-01-01)

Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
by: Kai-Yen Lan, et al.
Published: (2023-10-01)

<i>Clostridioides difficile</i> Infection in an Italian Tertiary Care University Hospital: A Retrospective Analysis
by: Alice Annalisa Medaglia, et al.
Published: (2023-04-01)

Next Generation Fecal Microbiota Transplantation
by: Tae-Geun Gweon, et al.
Published: (2021-03-01)

Clostridioides difficile infection: An emerging zoonotic disease
by: Abraham Joseph Pellissery, et al.
Published: (2022-06-01)

Gut Microbiota Composition and Clostridioides Difficile Infection: The Potential Protective Role of Faecalibacterium Prausnitzii
by: Nadim Cassir, et al.
Published: (2024-12-01)

Updated Management Guidelines for <i>Clostridioides difficile</i> in Paediatrics
by: Margherita Gnocchi, et al.
Published: (2020-04-01)

Symbiotic biofilms formed by Clostridioides difficile and bacteroides thetaiotaomicron in the presence of vancomycin
by: Jingpeng Yang, et al.
Published: (2024-12-01)

Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
by: Chun-Wei Chiu, et al.
Published: (2021-05-01)

Protective Effects of Huo Xiang Zheng Qi Liquid on <i>Clostridioides difficile</i> Infection on C57BL/6 Mice
by: Ming Chen, et al.
Published: (2024-08-01)

Comparison of rectal swabs and fecal samples for the detection of Clostridioides difficile infections with a new in-house PCR assay
by: Ann Huletsky, et al.
Published: (2024-06-01)

A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital
by: Adriana Maria Paixão de Sousa da Silva, et al.
Published: (2023-03-01)

Antibiotic associated diarrhea due to Clostridioides difficile in a tertiary care teaching hospital, central India
by: Sunandini Kapoor, et al.
Published: (2023-02-01)

ESTRATÉGIAS PARA REDUÇÃO DOS CASOS DE CLOSTRIDIOIDES DIFFICILE NA UNIDADE DE TERAPIA INTENSIVA: ABORDAGEM MULTIFATORIAL
by: Luciana Rodrigues da Silva, et al.
Published: (2023-10-01)

Adenosine receptors differentially mediate enteric glial cell death induced by Clostridioides difficile Toxins A and B
by: Deiziane V. S. Costa, et al.
Published: (2023-01-01)

Metronidazole and Vancomycin Have a Synergic Effect, with Plant Extracts as Helpful Tools to Combat <i>Clostridioides difficile</i> Infections
by: Nancy C. Ruiz-Pérez, et al.
Published: (2025-01-01)

<i>Clostridioides difficile</i> and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia
by: Kateřina Bogdanová, et al.
Published: (2021-10-01)

The vanRCd Mutation 343A>G, Resulting in a Thr115Ala Substitution, Is Associated with an Elevated Minimum Inhibitory Concentration (MIC) of Vancomycin in Clostridioides difficile Clinical Isolates from Florida
by: Ishani Wickramage, et al.
Published: (2023-06-01)

Susceptibility of Selected Multi-Drug Resistant Clinical Isolates to Different Leaf Extracts of Senna alata
by: Ibikunle Ibitayo ANIBIJUWON, et al.
Published: (2018-03-01)

New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation
by: Tomaž Bratkovič, et al.
Published: (2024-12-01)

Vancomycin below the standard level of blood concentration to treat a critically ill child
by: Zhuo Li, et al.
Published: (2023-08-01)

Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic <i>Clostridioides difficile</i> Colonization and Infection
by: Sung-Hee Han, et al.
Published: (2020-06-01)

High Prevalence of <i>Clostridioides difficile</i> Ribotype 176 in the University Hospital in Kosice
by: Katarina Curova, et al.
Published: (2023-03-01)